Photodynamic therapy using talaporfin sodium (laserphyrin®) for bile duct carcinoma: A preliminary clinical trial

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 4931-4938

  Nanashima, Atsushi ^a   Abo, Takafumi ^a   Nonaka, Takashi ^a   Nonaka, Yoshikazu ^a   Morisaki, Tomohito ^a   Uehara, Ryouhei ^a   Ohnita, Ken ^a   Fukuda, Daisuke ^a   Murakami, Goshi ^a   Tou, Kazuo ^a   Kunizaki, Masaki ^a   Hidaka, Shigekazu ^a   Tsuchiya, Tomoshi ^a   Takeshita, Hiroaki ^a   Nakao, Kazuhiko ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Adjuvant treatment; Bile duct carcinoma; Photodynamic therapy; Semiconductor laser; Talaporfin sodium

Indexed keywords

GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; PROTOPORPHYRIN; TALAPORFIN; UROPORPHYRIN;

ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CHOLANGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ENDOSCOPIC THERAPY; FEMALE; HUMAN; INFLAMMATION; LIVER DYSFUNCTION; LIVER METASTASIS; LOW LEVEL LASER THERAPY; MALE; MORTALITY; PHOTODERMATOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CARCINOMA; FEMALE; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 84872660429     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tamada K and Sugano K: Diagnosis and non-surgical treatment of bile duct carcinoma: developments in the past decade. J Gastroenterol 35: 319-325, 2000.
2. Ahrendt SA, Nakeeb A and Pitt HA: Cholangiocarcinoma. Clin Liver Dis 5: 191-218, 2001.
3. Nagakawa T, Kayahara M, Ikeda S, Futakawa S, Kakita A, Kawarada H, Matsuno M, Takada T, Takasaki K, Tanimura H, Tashiro S and Yamaoka Y: Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 9: 569-575, 2002.
4. Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F and Ochiai T: Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 27: 289-293, 2003.
5. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR and Wasan H; British Society of Gastroenterology: Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6): 7-9, 2002.
6. Bowling TE, Galbraith SM, Hatfield AR, Solano J and Spittle MF: A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 39: 852-855, 1996.
7. Indar AA, Lobo DN, Gilliam AD, Gregson R, Davidson I, Whittaker S, Doran J, Rowlands BJ and Beckingham IJ: Percutaneous biliary metal wall stenting in malignant obstructive jaundice. Eur J Gastroenterol Hepatol 15: 915-919, 2003.
8. Dolmans DE, Fukumura D and Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer 3: 380-387, 2003.
9. Berr F, Wiedmann M, Tannapfel A, Halm U, Kohlhaw KR and Mossner J: Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival. Hepatology 31: 291-298, 2000.
10. Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D and Wiedmann M: Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: Palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244: 230-239, 2006.
11. Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mössner J and Lochs H: Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study. Gastroenterology 125: 1355-1363, 2003.
12. Zoepf T, Jakobs R, Arnold JC, Apel D and Riemann JF: Palliation of nonresectable bile duct cancer: Improved survival after photodynamic therapy. Am J Gastroenterol 100: 2426-2430, 2005.
13. Nanashima A, Yamaguchi H, Shibasaki S, Ide N, Sawai T, Tsuji T, Hidaka S, Sumida Y, Nakagoe T and Nagayasu T: Adjuvant photodynamic therapy for bile duct carcinoma after surgery: A preliminary study. J Gastroenterol 39: 1095-1101, 2004.
14. Usuda J, Kata H, Okunaka T, Furukawa K, Tsutsui H, Yamada K, Suga Y, Honda H, Nagatsuka Y, Ohira T, Tsuboi M and Hirano T: Photodynamic therapy for lung cancer. J thoracic oncol 1: 489-493, 2006.
15. Kato H, Furukawa K, Sato M, Okunaka T, Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K and Shiraishi T: Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 42: 103-111, 2003.
16. Zheng H: A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4: 283-293, 2005.
17. Ferrario A, Kessel D and Gomer CJ: Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res 52: 2890-2893, 1992.
18. Roberts WG, Smith KM, McCullough JL and Berns MW: Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem Photobiol 49: 431-438, 1989.
19. Nonaka T, Nanashima A, Nonaka M, Uehara M, Isomoto H, Asahina I, Nagayasu T: Analysis of apoptotic effects induced by photodynamic therapy in a human biliary cancer cell line. Anticancer Res 30: 2113-2118, 2010.
20. Nonaka T, Nanashima A, Nonaka M, Uehara M, Isomoto H, Nonaka Y and Nagayasu T: Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma. J Hepatobiliary Pancreat Sci 18: 592-600, 2011.
21. Japanese Society of Biliary Surgery (JSBS). Part II extrahepatic bile duct. In: Nagakawa T (eds.). Classification of Biliary Tract Carcinoma. First English ed. Tokyo: Kanehara & Co., Ltd., pp. 12-32, 2001
22. Dougherty TJ: Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol 2: 83-116, 1984.
23. Takeda K, Shinohara Y, Takei K, Itoi T, Nakamura K and Saito T: Photodynamic therapy for bile duct cancer (in Japanese). Rinsyou Syoukaki Naika (Clin Gastroenterol) 14: 1171-1176, 1999.
24. Yoshida T, Tokashiki R, Ito H, Shimizu A, Nakamura K, Hiramatsu H, Tsukahara K, Shimizu S, Takata D, Okamoto I and Suzuki M: Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration. Auris Nasus Larynx 35: 545-551, 2008.
25. Ortner MA: Photodynamic therapy for cholangiocarcinoma: Overview and new developments. Curr Opin Gastroenterol 25: 472-476, 2009.
26. Allison RR, Zervos E and Sibata CH: Cholangiocarcinoma: An emerging indication for photodynamic therapy. Photodiagnosis Photodyn Ther 6: 84-92, 2009.
27. Choi HJ, Moon JH, Ko BM, Min SK, Song AR, Lee TH, Cheon YK, Cho YD and Park SH: Clinical feasibility of direct peroral cholangioscopy-guided photodynamic therapy for inoperable cholangiocarcinoma performed by using an ultra-slim upper endoscope (with videos). Gastrointest Endosc 73: 808-813, 2011.
28. Saito H, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, Furuse J, Tsuyuguchi T, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Amano H and Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology: Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 15: 63-68, 2008.
29. Roberts WG, Shiau FY, Nelson JS, Smith KM and Berns MW: In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy. J Natl Cancer Inst 80: 330-336, 1988.
30. Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C and Goetz AE: Distribution and pharmacokinetics of photofrin in human bile duct cancer. J Photochem Photobiol B 47: 58-62, 1998.
31. Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J and Witzigmann H: Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: A phase II pilot study. Cancer 97: 2783-2790, 2003.
32. Rumalla A, Baron TH, Wang KK, Gores GJ, Stadheim LM and de Groen PC: Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 53: 500-504, 2001.
33. Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR and Pereira SP: R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 31: 99-107, 2011.
34. Nanashima A, Tobinaga S, Abo T, Machino R, Takeshita H, Nonaka T, Hidaka S, Tanaka K, Kunizaki M, Sawai T, Yasutake T and Nagayasu T: Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute. Hepatogastroenterology 59: 347-350, 2012.
35. Höblinger A, Gerhardt T, Gonzalez-Carmona MA, Hüneburg R, Sauerbruch T and Schmitz V: Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma. Eur J Med Res 16: 391-395, 2011.
36. Katayose Y, Rikiyama T, Motoi F, Yamamoto K, Yoshida H, Morikawa T, Hayashi H, Kanno A, Hirota M, Satoh K, Ariga H, Suzuki M, Ohyauchi M, Kondo Y, Ikeya S, Ogawa Y, Shimosegawa T, Egawa S and Unno M: Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study). Hepatogastroenterology 58: 1866-1872, 2011.
37. Atsushi Nanashima, Takafumi Abo, Tomohito Morisaki, Ryohei Uehara, Ryosuke Mishima, Ken Onita and Hajime Isomoto: Report of three cases regarding safety of photodynamic therapy using a new photosensitizer, Laserphyrin, in bile duct carcinoma. (in Japanese) J Jpn Biliary Assoc 25: 220-227, 2011.